Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss. (Record no. 29863318)

MARC details
000 -LEADER
fixed length control field 01632 a2200457 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518045856.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202010s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2045-2322
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/s41598-019-45964-9
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sheth, Sandeep
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20201022
245 00 - TITLE STATEMENT
Title Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Scientific reports
Date of publication, distribution, etc. 07 2019
300 ## - PHYSICAL DESCRIPTION
Extent 9571 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apoptosis
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Caffeine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Central Nervous System Stimulants
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cochlea
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorescent Antibody Technique
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hearing Loss
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inflammation
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rats
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Synaptic Potentials
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sheehan, Kelly
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dhukhwa, Asmita
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Al Aameri, Raheem F H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mamillapalli, Chaitanya
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mukherjea, Debashree
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rybak, Leonard P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ramkumar, Vickram
773 0# - HOST ITEM ENTRY
Title Scientific reports
Related parts vol. 9
-- no. 1
-- p. 9571
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/s41598-019-45964-9">https://doi.org/10.1038/s41598-019-45964-9</a>
Public note Available from publisher's website

No items available.